Former Senior Partner at McKinsey & Company

NY 2026 Independent Pharmacies
OIG Controlled Substance Obstruction
Penalty
$650 million

Outcome

OIG enforcement action against Former Senior Partner at McKinsey & Company for controlled substance, obstruction. Penalty: $650 million.

Details

Former Senior Partner at McKinsey & Company — OIG Enforcement (2026)

OIG took enforcement action against Former Senior Partner at McKinsey & Company in NY in 2026 involving controlled substance, obstruction violations in the Independent Pharmacies sector.

Penalty: $650 million

Violation types: Controlled Substance, Obstruction
Entity type: Healthcare Provider
Penalty type: Criminal
Location: NY

Source: Former Senior Partner at McKinsey & Company Pleads Guilty

How Crucible Prevents This

Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping. Crucible's immutable audit trail prevents records from being altered or destroyed, and its document retention enforcement ensures compliance with record-keeping requirements.

Source: Former Senior Partner at McKinsey & Company Pleads Guilty

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works